Topic

Washington

A collection of 489 issues

Renewing Zanzalintinib (XL092) Coverage with Humana in Washington: Timeline, Documentation & Appeal Steps

Answer Box: Renewing Zanzalintinib (XL092) Coverage with Humana in Washington Zanzalintinib (XL092) is an investigational drug requiring compassionate use program enrollment through Exelixis, as it's not FDA-approved. Humana typically covers investigational drugs only within clinical trials or approved compassionate use programs. To renew coverage: (1) Confirm continued eligibility
6 min read

Renewing Vitrakvi (Larotrectinib) Approval with Humana in Washington: Timeline, Documentation & Appeals Guide

Answer Box: Renewing Vitrakvi Coverage with Humana in Washington Vitrakvi (larotrectinib) requires prior authorization renewal with Humana every 3-6 months. Start your renewal 30-45 days before expiration. Submit: updated clinical notes showing continued benefit, recent imaging demonstrating response/stable disease, current liver function tests, and NTRK fusion documentation. If denied,
6 min read

How to Get Tepezza (Teprotumumab) Covered by Aetna CVS Health in Washington: Prior Authorization Forms, Appeal Process & Success Strategies

Answer Box: Getting Tepezza Covered by Aetna CVS Health in Washington Fastest path to approval: Your ophthalmologist submits Aetna's Tepezza Precertification Form with documented moderate-to-severe TED diagnosis and evidence of failed step therapy (prednisone, methimazole). If denied, file internal appeals within 180 days, then request external review through
5 min read

Myths vs. Facts: Getting StrataGraft Covered by Cigna in Washington (Appeals Guide & Documentation Tips)

Answer Box: Getting StrataGraft Covered by Cigna in Washington StrataGraft requires prior authorization from Cigna and is only covered for FDA-approved deep partial-thickness thermal burns in adults. Common myths include believing all doctor prescriptions are automatically covered and that pharmacy billing is correct. Reality: You need detailed burn documentation, proper
5 min read